News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News EuroPCR 2019 ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety L.A. McKeown May 31, 2019
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ISC 2017 Triple Antiplatelet Therapy Does Not Cut New Events in Acute Ischemic Stroke or TIA Todd Neale February 23, 2017
News Conference News AHA 2015 CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure Shelley Wood November 08, 2015
News Conference News TCT 2015 Discussion Highlights Merits, Limitations of Small Trials Yael L. Maxwell October 13, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Conference News TCT 2013 Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias November 04, 2013
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News AHA 2012 No Mortality Benefit with Prolonged Dual Antiplatelet Therapy November 05, 2012
News Conference News ESC 2012 WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants Yael L. Maxwell August 28, 2012
News Conference News RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets August 31, 2011
News Conference News EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES Caitlin E. Cox April 05, 2011